Peter Thiel, Director at AbCellera Biologics Inc. (ABCL), bought 3,382,357 shares at $20.00 ($60.0M) on 2020-12-15, disclosed to the SEC on 2020-12-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 382,357 | $0 | 0.0% |
| 2 | $20.00 | 3,000,000 | $60.0M | 100.0% |
| Total | $17.74 avg | 3,382,357 | $60.0M | 100% |
| Filing → |
| PLTR | SELL | 2024-09-26 | $1.2B | — | Filing → |
| PLTR | SELL | 2024-05-10 | $443.0M | — | Filing → |
| PLTR | SELL | 2024-03-12 | $349.2M | — | Filing → |